Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study-Reference-Cited by-同舟云学术

Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study

Published:2020-09-02 Issue:9 Volume:15 Page:e0238476
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Souza Kathiaja Miranda^ORCID,Diniz Isabela Maia,Lemos Lívia Lovato Pires de,Junior Nélio Gomes Ribeiro,Zuppo Isabella de Figueiredo^ORCID,Teodoro Juliana Alvares,Acurcio Francisco de Assis,Atallah Álvaro Nagib,Júnior Augusto Afonso Guerra

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Epidemiology of Multiple Sclerosis;J Howard;Neurol Clin,2016

2. Defining the clinical course of multiple sclerosis: The 2013 revisions;FD Lublin;Neurology,2014

3. Multiple sclerosis;A Compston;Lancet,2008

4. Prevalence of multiple sclerosis in Brazil: A systematic review;A Beatriz;Mult Scler Relat Disord,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pattern of disease-modifying therapies use and related adverse events among multiple sclerosis patients;Brazilian Journal of Pharmaceutical Sciences;2024

2. Severity of white matter microstructural damage in a Brazilian relapsing-remitting multiple sclerosis cohort: A possible window to optimize treatment;The Neuroradiology Journal;2023-11-01

3. IgM to phosphatidylcholine in multiple sclerosis patients: from the diagnosis to the treatment;Therapeutic Advances in Neurological Disorders;2023-01

4. Course of therapy in patients with active relapsing-remitting multiple sclerosis despite first-line treatment;Postępy Psychiatrii i Neurologii;2023

5. Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-β;Scientific Reports;2022-08-03